Average Co-Inventor Count = 8.03
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (12 from 3,923 patents)
2. Vicuron Pharmaceuticals Inc. (1 from 23 patents)
3. Vicuron Holdings LLC (1 from 1 patent)
4. Novartis Pharma Gmbh (8 patents)
13 patents:
1. 12209144 - Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
2. 9206232 - Organic compounds and their uses
3. 8840878 - Peptidomimetic sulfamide compounds and antiviral uses thereof
4. 8613914 - Peptidomimetic sulfamide compounds and antiviral uses thereof
5. 8512690 - Derivatised proline containing peptide compounds as protease inhibitors
6. 8445527 - Organic compounds and their uses
7. 8324239 - Furopyridine compounds and uses thereof
8. 8222425 - Organic compounds and their uses
9. 8211932 - Organic compounds and their uses
10. 8044199 - N-formyl hydroxylamines compounds
11. 8008263 - Organic compounds and their uses
12. 7825152 - Organic compounds and their uses
13. 7615635 - N-formyl hydroxylamines